PRIMPOL and neoplasm: If PRIMPOL exerts a critical anti-mutagenic activity, the overall frequency of point mutations, as determined by exome sequencing, is expected to increase in PRIMPOL deficient tumours as compared to the majority of PRIMPOL proficient tumours.